From GlobeNewswire:

iTeos Therapeutics, Inc. announced that President and CEO Dr. Michel Detheux will be speaking at the 42nd annual J.P. Morgan Healthcare Conference on January 10, 2024, at 3:00 PM PST. A webcast will be available on the company’s website, and an archived recording will be available for approximately 30 days after the presentation.

The company is a clinical-stage biopharmaceutical company pioneering the development of a new generation of immuno-oncology therapeutics. iTeos Therapeutics is focused on researching and developing innovative product candidates that have the potential to restore the immune response against cancer. Its headquarters are in Watertown, Massachusetts, and it has a research center in Gosselies, Belgium.

iTeos Therapeutics regularly publishes important information for investors in the “Investors” section of its website at www.iteostherapeutics.com and encourages investors to visit the site regularly for updates.

For more information, contact: Carl Mauch, iTeos Therapeutics, Inc., at [email protected] for investor inquiries, and [email protected] for media inquiries.



Read more: iTeos hält auf der 42. jährlichen Gesundheitskonferenz von